Pet Cancer Therapeutics Market
- 2026 年市場規模
- USD 11.7 Bn
- 2033 年預估規模
- USD 18.7 Bn
- 年複合成長率 CAGR
- 8.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Pet Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Targeted Therapy, Combination Therapy, and Immunotherapy), By Pet Type (Cat, Dog, and Horse), By Mode of Administration (Oral, Intravenous, and Topical), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.
Market Dynamics
The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.
Key features of the study
• This report provides in-depth analysis of pet cancer therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global pet cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market
Market Segmentation
• By Therapy Type: (Revenue, USD Bn, 2021-2033)
o Chemotherapy
o Targeted Therapy
o Combination Therapy
o Immunotherapy
• By Pet Type: (Revenue, USD Bn, 2021-2033)
o Cat
o Dog
o Horse
• By Mode of Administration: (Revenue, USD Bn, 2021-2033)
o Oral
o Intravenous
o Topical
• By Application: (Revenue, USD Bn, 2021-2033)
o Lymphoma
o Mast Cell Cancer
o Melanoma
o Mammary and Squamous Cell Cancer
o Others
• By Region: (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Aratana Therapeutics, Inc.
o AB Science
o Boehinger Ingelheim International GmbH
o Zenoaq
o Morphogenesis, Inc.
o VetDC, Inc.
o Karyopharm Therapeutics, Inc.
o Regeneus Ltd.
o Rhizen Pharmaceuticals SA
o Oasmia Pharmaceuticals AB
o Zoetis
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Therapy Type
Market Snippet, By Pet Type
Market Snippet, By Mode of Administration
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Key Highlights
o Pipeline Analysis
o Regulatory Guidelines
o Initiatives for Prevention of Pet Cancer
o Approved Targeted Therapies for Pet Cancer
o Epidemiology
4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Combination Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Pet Cancer Therapeutics Market, By Pet Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Cat
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Dog
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Horse
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Pet Cancer Therapeutics Market, By Application, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Mast Cell Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Melanoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Mammary and Squamous Cell Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Pet Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022-2033
o North America
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
Market Size and Forecast, By Application, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
Aratana Therapeutics, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
AB Science
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Boehringer Ingelheim International GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Zenoaq
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Morphogenesis, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
VetDC, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Karyopharm Therapeutics, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Rhizen Pharmaceuticals SA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Regeneus Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Oasmia Pharmaceuticals AB
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
Zoetis
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Analyst Views
10. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們